View Older Stories View More Recent Stories

Jul 31, 2024 11:15AM Moderna (MRNA) August weekly option IV elevated into quarter results
Jul 31, 2024 05:01AM Moderna (MRNA) August 2 weekly 120 straddle priced into quarter results
Jul 29, 2024 07:04AM GSK (GSK) and Flagship Pioneering partner to discover novel medicines and vaccines
Jul 23, 2024 10:35AM Moderna (MRNA) Appoints David Rubenstein to its Board
Jul 23, 2024 07:14AM Moderna (MRNA) Announces Resignations of Robert Langer and Stephen Berenson from Board
Jul 23, 2024 07:00AM David Rubenstein Joins Moderna's Board of Directors
Jul 10, 2024 07:00AM Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024
Jul 9, 2024 05:41AM Moderna (MRNA) Partners with Mitsubishi Tanabe Pharma to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Japan, Including COVID-19 Vaccines
Jul 8, 2024 07:00PM Moderna And Mitsubishi Tanabe Pharma Corporation Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Japan, Including COVID-19 Vaccines
Jul 3, 2024 05:22AM Moderna (MRNA) option IV flat into quarter results
Jul 2, 2024 07:31AM Moderna (MRNA) Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
Jul 2, 2024 07:30AM Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
Jul 2, 2024 07:18AM US Inks Vaccine Deal With Moderna (MRNA) as Bird Flu Threat Looms - Bloomberg
Jun 28, 2024 11:54AM Midday movers: Nike and Accolade fall; Humana and Infinera rise
Jun 28, 2024 07:02AM Moderna (MRNA) Reports Positive EMA Opinion Recommending Marketing Authorization of mRESVIA
Jun 28, 2024 07:00AM EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)
Jun 27, 2024 12:31PM TD Cowen Reiterates Hold Rating on Moderna (MRNA)
Jun 27, 2024 11:28AM Moderna (MRNA) July 5 weekly 116 puts and July 125 puts active amid wide price movement
Jun 27, 2024 07:53AM Piper Sandler Reiterates Overweight Rating on Moderna (MRNA)
Jun 26, 2024 10:34AM Jefferies Reiterates Buy Rating on Moderna (MRNA)
Jun 26, 2024 10:08AM Moderna (MRNA) sees heavy early weakness amid CDC presentation
Jun 20, 2024 02:33PM Moderna (MRNA) PT Raised to $150 at Argus
Jun 14, 2024 07:46AM TD Cowen Reiterates Hold Rating on Moderna (MRNA)
Jun 13, 2024 07:02AM Moderna (MRNA) Reports Positive Phase 3 Efficacy Data for mRNA-1283
Jun 13, 2024 07:00AM Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccine
Jun 12, 2024 07:45AM Moderna (MRNA) price target raised at Oppenheimer after RSV vaccine approval
Jun 12, 2024 06:36AM Moderna (MRNA) PT Raised to $179 at Oppenheimer, 'mResvia is competitive as an RSV vaccine'
Jun 10, 2024 01:54PM Moderna (MRNA): expects to file for approval of RSV vaccine in adults aged 18 to 59 this year - Company executive at conference
Jun 10, 2024 11:28AM Midday movers: Southwest Airlines, CrowdStrike, KKR rise; AMD falls
Jun 10, 2024 08:58AM Brookline Capital Markets Reiterates Buy Rating on Moderna (MRNA)
Jun 10, 2024 06:52AM Morgan Stanley Reiterates Equalweight Rating on Moderna (MRNA)
Jun 10, 2024 06:52AM Jefferies on Moderna (MRNA): 'Phase III Flu/Covid Combo looks good - could be on market in 2025'
Jun 10, 2024 06:30AM Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Jun 10, 2024 05:31AM Moderna (MRNA) Reports Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
View More Recent Stories View Older Stories